Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma
- PMID: 23791398
- PMCID: PMC3783651
- DOI: 10.1016/j.humpath.2013.02.022
Melanogenesis affects overall and disease-free survival in patients with stage III and IV melanoma
Abstract
Because melanogenesis can affect immune responses to and chemotherapy and radiotherapy for melanoma, we analyzed overall survival and disease-free survival times in melanoma patients in relation to the degree of tumor pigmentation. Clinicopathologic data were obtained from the Oncology Centre, Prof Franciszek Łukaszczyk Memorial Hospital, Bydgoszcz, Poland. The overall survival and disease-free survival analyses were performed using the log-rank test, whereas differences between mean/median overall survival and disease-free survival (days) were analyzed using the Student t test. In patients with metastatic disease, those with melanotic melanomas exhibited significantly shorter disease-free survival and overall survival than those with amelanotic lesions. Similarly, melanin-producing lymph node metastases were linked to shorter overall survival and disease-free survival, which was confirmed by a significantly longer mean/median disease-free survival for amelanotic versus melanotic metastases. Melanogenesis shortens overall survival and disease-free survival in patients with metastatic melanoma. Inhibition of melanogenesis appears a rational adjuvant approach to the therapy of metastatic melanoma.
Keywords: Melanin; Melanogenesis; Melanoma; Metastatic melanoma; Survival.
Copyright © 2013 Elsevier Inc. All rights reserved.
Figures
References
-
- Slominski A, Tobin DJ, Shibahara S, Wortsman J. Melanin pigmentation in mammalian skin and its hormonal regulation. Physiol Rev. 2004;84:1155–1228. - PubMed
-
- Meyskens FL, Jr, Farmer PJ, Yang S, Anton-Culver H. New perspectives on melanoma pathogenesis and chemoprevention. Recent Results Cancer Res. 2007;174:191–195. - PubMed
-
- Lazova R, Pawelek JM. Why do melanomas get so dark? Exp Dermatol. 2009;18:934–938. - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
